Anti-Human PD-1 & CTLA-4 Bispecific Reference Antibody (Vudalimab, RUO)
Overview
| Catalog No. |
HS870226 |
| Brand |
abinScience |
| Host species |
Human |
| Species reactivity |
Human |
| Form |
Liquid |
| Storage buffer |
0.01M PBS pH 7.4. |
| Purity |
>95% as determined by SDS-PAGE. |
| Clonality |
Monoclonal |
| Isotype |
half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3 |
| Applications |
ELISA, Bioactivity: FCM, Functional assay, Research in vivo |
| Target |
CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1, PD-1, CD152, CTLA-4, CTLA4, Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4 |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Endotoxin level |
< 10 EU/mg as determined by LAL method. |
| Accession |
Q15116 & P16410 |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | Bispecific, XmAb-20717, XMAB20717, 2329669-72-7 |
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control |
Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507) |
Images
 Bioactivity |
Detects CD279/PDCD1/PD1 in indirect ELISAs. |